Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis

References

• Alemany, S., B. Arias, M. Fatjo-Vilas, H. Villa, J. Moya, M. I. Ibanez, G. Ortet, C. Gasto, and L. Fananas. 2014. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes. Acta Psychiatrica Scandinavia 129 (1):54–62. doi:10.1111/acps.12108.
   PubMed Web of Science ®Google Scholar
• Anthony, J. C., L. A. Warner, and R. C. Kessler. 1994. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2 (3):244–68. doi:10.1037/1064-1297.2.3.244.
   Web of Science ®Google Scholar
• Baggio, S., J. Studer, M. Mohler-Kuo, J. B. Daeppen, and G. Gmel. 2014. Non-medical prescription drug and illicit street drug use among young Swiss men and associated mental health issues. International Journal of Adolescencent Medicine and Health 26 (4):525–30.
   PubMedGoogle Scholar
• Bahr, S. J., J. P. Hoffmann, and X. Yang. 2005. Parental and peer influences on the risk of adolescent drug use. Journal of Primary Prevention 26 (6):529–51. doi:10.1007/s10935-005-0014-8.
   PubMedGoogle Scholar
• Baker, A., and S. Dawe. 2005. Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist 40 (2):88–95. doi:10.1080/00050060500094654.
   Web of Science ®Google Scholar
• Bao, Y. P., Y. Qiu, S. Y. Yan, Z. J. Jia, S. X. Li, Z. Lian, Y. Mu, and Z. M. Liu. 2013. Pattern of drug use and depressive symptoms among amphetamine type stimulants users in Beijing and Guangdong province, China. PloS one 8 (4):e60544. doi:10.1371/journal.pone.0060544.
   PubMed Web of Science ®Google Scholar
• Barnwell, S. S., M. Earleywine, and R. Wilcox. 2006. Cannabis, motivation, and life satisfaction in an internet sample. Substance Abuse, Treatement, Prevention, and Policy 1:2. doi:10.1186/1747-597X-1-2.
   PubMed Web of Science ®Google Scholar
• Bech, P., N. A. Rasmussen, L. R. Olsen, V. Noerholm, and W. Abildgaard. 2001. The sensitivity and specificity of the Major Depression Inventory, Using The Present State Examination as the index of diagnostic validity. Journal of Affective Disorders 66 (2–3):159–64.
   PubMed Web of Science ®Google Scholar
• Brady, K. T., and R. Sinha. 2005. Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. American Journal of Psychiatry 162 (8):1483–93. doi:10.1176/appi.ajp.162.8.1483.
   PubMed Web of Science ®Google Scholar
• Cohen, S., T. Kamarck, and R. Mermelstein. 1983. A global measure of perceived stress. Journal of Health and Social Behavior 24 (4):385–96.
   PubMed Web of Science ®Google Scholar
• Copeland, J., S. Rooke, and W. Swift. 2013. Changes in cannabis use among young people: Impact on mental health. Current Opinion Psychiatry 26 (4):325–29. doi:10.1097/YCO.0b013e328361eae5.
   PubMed Web of Science ®Google Scholar
• Cuttler, C., A. Spradlin, and R. J. McLaughlin. 2018. A naturalistic examination of the perceived effects of cannabis on negative affect. Journal of Affective Disorders 235:198–205. doi:10.1016/j.jad.2018.04.054.
   PubMed Web of Science ®Google Scholar
• Danielson, C. K., A. B. Amstadter, R. E. Dangelmaier, H. S. Resnick, B. E. Saunders, and D. G. Kilpatrick. 2009. Trauma-related risk factors for substance abuse among male versus female young adults. Addictive Behaviors 34 (4):395–99. doi:10.1016/j.addbeh.2008.11.009.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., and W. Hall. 2012. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet 379 (9810):55–70. doi:10.1016/S0140-6736(11)61138-0.
   PubMed Web of Science ®Google Scholar
• Diener, E., R. A. Emmons, R. J. Larsen, and S. Griffin. 1985. The satisfaction with life scale. Journal of Personal Assessment 49 (1):71–75. doi:10.1207/s15327752jpa4901_13.
   PubMed Web of Science ®Google Scholar
• Dube, S. R., V. J. Felitti, M. Dong, D. P. Chapman, W. H. Giles, and R. F. Anda. 2003. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study. Pediatrics 111 (3):564–72.
   PubMed Web of Science ®Google Scholar
• Fergusson, D. M., and J. M. Boden. 2008. Cannabis use and later life outcomes. Addiction. 103 (6):969–76. discussion 977-8. doi:10.1111/j.1360-0443.2008.02221.x.
   PubMed Web of Science ®Google Scholar
• Foa, E. B., L. Cashman, L. Jaycox, and K. Perry. 1997. The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychological Assessment 9 (4):445–51. doi:10.1037/1040-3590.9.4.445.
   Web of Science ®Google Scholar
• Fothergill, K., M. E. Ensminger, E. E. Doherty, H. S. Juon, and K. M. Green. 2016. Pathways from early childhood adversity to later adult drug use and psychological distress: A prospective study of a cohort of African Americans. Journal of Health and Social Behavior 57 (2):223–39. doi:10.1177/0022146516646808.
   PubMed Web of Science ®Google Scholar
• Gray, M. J., B. T. Litz, J. L. Hsu, and T. W. Lombardo. 2004. Psychometric properties of the life events checklist. Assessment 11 (4):330–41. doi:10.1177/1073191104269954.
   PubMed Web of Science ®Google Scholar
• Haasen, C., M. Prinzleve, M. Gossop, G. Fischer, and M. Casas. 2005. Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry : Official Journal of the World Psychiatric Association (WPA) 4 (3):173–76.
   PubMedGoogle Scholar
• Hall, W. 2015. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 110 (1):19–35. doi:10.1111/add.12703.
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., C. B. Thorne, C. B. Clark, D. W. Coombs, and M. W. Johnson. 2015. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology 29 (3):280–88. doi:10.1177/0269881114565653.
   PubMed Web of Science ®Google Scholar
• Heyne, A., T. May, P. Goll, and J. Wolffgramm. 2000. Persisting consequences of drug intake: Towards a memory of addiction. Journal of Neural Transmission 107 (6):613–38. doi:10.1007/s007020070065.
   PubMed Web of Science ®Google Scholar
• Hibell, B., U. Guttormsson, S. Ahlström, O. Balakireva, T. Bjarnason, A. Kokkevi, and L. Kraus. 2012. The 2011 ESPAD report. Substance use among students in 36 European Countries. Tukholma: The Swedish Council for Information on Alcohol and other Drugs. Viitattu.
   Google Scholar
• Hooper, L. M., P. Stockton, J. L. Krupnick, and B. L. Green. 2011. Development, Use, and Psychometric Properties of the Trauma History Questionnaire. Journal of Loss and Trauma 16 (3):258–83. doi:10.1080/15325024.2011.572035.
   Web of Science ®Google Scholar
• Huizink, A. C., R. F. Ferdinand, J. van der Ende, and F. C. Verhulst. 2006. Symptoms of anxiety and depression in childhood and use of MDMA: Prospective, population based study. British Medical Journal 332 (7545):825–28. doi:10.1136/bmj.38743.539398.3A.
   PubMed Web of Science ®Google Scholar
• Hyman, S. E. 2005. Addiction: A disease of learning and memory. American Journal of Psychiatry 162 (8):1414–22. doi:10.1176/appi.ajp.162.8.1414.
   PubMed Web of Science ®Google Scholar
• Johansen, P.-Ø., and T. S. Krebs. 2015. Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology 29 (3):270–79. doi:10.1177/0269881114568039.
   PubMed Web of Science ®Google Scholar
• Jungaberle, H. 2008. Therapie mit psychoaktiven Substanzen: Praxis und Kritik der Psychotherapie mit LSD, Psilocybin und MDMA. Bern: Huber.
   Google Scholar
• Karila, L., P. Roux, B. Rolland, A. Benyamina, M. Reynaud, H. J. Aubin, and C. Lancon. 2014. Acute and long-term effects of cannabis use: A review. Current Pharmaceutical Design 20 (25):4112–18.
   PubMed Web of Science ®Google Scholar
• Kedzior, K. K., and L. T. Laeber. 2014. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population–A meta-analysis of 31 studies. BMC Psychiatry 14:136. doi:10.1186/1471-244X-14-136.
   PubMed Web of Science ®Google Scholar
• Kendler, K. S., C. A. Prescott, J. Myers, and M. C. Neale. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry 60 (9):929–37. doi:10.1001/archpsyc.60.9.929.
   PubMed Web of Science ®Google Scholar
• Keyes, K. M., S. S. Martins, and D. S. Hasin. 2008. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 97 (1–2):139–49. doi:10.1016/j.drugalcdep.2008.04.001.
   PubMed Web of Science ®Google Scholar
• Kogan, S. M., J. Cho, A. Oshri, and J. MacKillop. 2017. The influence of substance use on depressive symptoms among young adult black men: The sensitizing effect of early adversity. American Journal on Addictions 26 (4):400–06. doi:10.1111/ajad.12555.
   PubMed Web of Science ®Google Scholar
• Krebs, T. S., and P. O. Johansen. 2013. Psychedelics and mental health: A population study. PloS one 8 (8):e63972. doi:10.1371/journal.pone.0063972.
   PubMed Web of Science ®Google Scholar
• Levant, R. F., and D. J. Wimer. 2014. Masculinity constructs as protective buffers and risk factors for men’s health. American Journal of Mens Health 8 (2):110–20. doi:10.1177/1557988313494408.
   PubMedGoogle Scholar
• Lieb, R., C. G. Schuetz, H. Pfister, K. von Sydow, and H. Wittchen. 2002. Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug and Alcohol Dependence 68 (2):195–207. doi:10.1016/S0376-8716(02)00190-4.
   PubMed Web of Science ®Google Scholar
• Marconi, A., M. Di Forti, C. M. Lewis, R. M. Murray, and E. Vassos. 2016. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin 42 (5):1262–69. doi:10.1093/schbul/sbw003.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., L. Luborsky, G. E. Woody, and C. P. O’Brien. 1980. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disorder 168 (1):26–33. doi:10.1097/00005053-198001000-00006.
   PubMed Web of Science ®Google Scholar
• Miller, P., and M. Plant. 2003. The family, peer influences and substance use: findings from a study of uk teenagers. Journal Of Substance Use 8 (1):19-26. doi: 10.1080/1465989021000067209.
   Google Scholar
• Mithoefer, M. C., C. S. Grob, and T. D. Brewerton. 2016. Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA. Lancet Psychiatry 3 (5):481–88. doi:10.1016/S2215-0366(15)00576-3.
   PubMed Web of Science ®Google Scholar
• Montgomery, C., J. E. Fisk, and L. Craig. 2008. The effects of perceived parenting style on the propensity for illicit drug use: The importance of parental warmth and control. Drug and Alcohol Review 27 (6):640–49. doi:10.1080/09595230802392790.
   PubMed Web of Science ®Google Scholar
• Moonzwe, L. S., J. J. Schensul, and K. M. Kostick. 2011. The role of MDMA (Ecstasy) in coping with negative life situations among urban young adults. Journal of Psychoactive Drugs 43 (3):199–210. doi:10.1080/02791072.2011.605671.
   PubMed Web of Science ®Google Scholar
• Nakagawa, S., and I. C. Cuthill. 2007. Effect size, confidence interval and statistical significance: A practical guide for biologists. Bioligical Reviews of the Cambridge Philosophical Society 82 (4):591–605. doi:10.1111/j.1469-185X.2007.00027.x.
   PubMed Web of Science ®Google Scholar
• Olsen, L. R., D. V. Jensen, V. Noerholm, K. Martiny, and P. Bech. 2003. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychological Medicine 33 (2):351–56.
   PubMed Web of Science ®Google Scholar
• Parks, K. A., and C. L. Kennedy. 2004. Club drugs: Reasons for and consequences of use. Journal of Psychoactive Drugs 36 (3):295–302. doi:10.1080/02791072.2004.10400030.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C. 2014. The potential dangers of using MDMA for psychotherapy. Journal of Psychoactive Drugs 46 (1):37–43. doi:10.1080/02791072.2014.873690.
   PubMed Web of Science ®Google Scholar
• Patel, R., and D. Titheradge. 2015. MDMA for the treatment of mood disorder: All talk no substance? Therapeutic Advances in Psychopharmacology 5 (3):179–88. doi:10.1177/2045125315583786.
   PubMed Web of Science ®Google Scholar
• Peralta, R. L., B. C. Stewart, J. L. Steele, and F. A. Wagner. 2016. Nonmedical use of prescription drugs in emerging adulthood: Differentiating sex from gender. Addiction Research and Theory 24 (5):389–97. doi:10.3109/16066359.2016.1140745.
   PubMed Web of Science ®Google Scholar
• Pries, L. K., S. Guloksuz, M. Ten Have, R. de Graaf, S. van Dorsselaer, N. Gunther, C. Rauschenberg, U. Reininghaus, R. Radhakrishnan, M. Bak, et al. 2018. Evidence that environmental and familial risks for psychosis additively impact a multidimensional subthreshold psychosis syndrome. Schizophrenia Bulletin 44 (4):710–19. doi:10.1093/schbul/sby051.
   PubMed Web of Science ®Google Scholar
• Prinzleve, M., C. Haasen, H. Zurhold, J. L. Matali, E. Bruguera, J. Gerevich, E. Bacskai, N. Ryder, S. Butler, V. Manning, et al. 2004. Cocaine use in Europe - a multi-centre study: Patterns of use in different groups. European Addiction Research 10 (4):147–55. doi:10.1159/000079835.
   PubMed Web of Science ®Google Scholar
• Rao, U., C. L. Hammen, and R. E. Poland. 2009. Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: Interactions between stress and HPA activity. American Journal of Psychiatry 166 (3):361–69. doi:10.1176/appi.ajp.2008.08030412.
   PubMed Web of Science ®Google Scholar
• Rougemont-Bücking, A., V. S. Grazioli, J. B. Daeppen, G. Gmel, and J. Studer. 2017. Family-related stress versus external stressors: Differential impacts on alcohol and illicit drug use in young men. European Addiction Research 23 (6):284–97. doi:10.1159/000485031.
   PubMed Web of Science ®Google Scholar
• Sawilowsky, S. S. 2009. New effect size rules of thumb. Journal of Modern Applied Statistical Methods 8 (2):597–99. doi:10.22237/jmasm/1257035100.
   Google Scholar
• Schellekens, A. F., B. Franke, B. Ellenbroek, A. Cools, C. A. de Jong, J. K. Buitelaar, and R. J. Verkes. 2013. COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence. Addiction Biology 18 (2):344–56. doi:10.1111/j.1369-1600.2012.00438.x.
   PubMed Web of Science ®Google Scholar
• Scott, R. M., L. Hides, J. S. Allen, and D. I. Lubman. 2013. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users. Addictive Behaviors 38 (10):2465–72. doi:10.1016/j.addbeh.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Sinha, R. 2008. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141:105–30. doi:10.1196/annals.1441.030.
   PubMed Web of Science ®Google Scholar
• Studerus, E., M. Kometer, F. Hasler, and F. X. Vollenweider. 2011. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies. Journal of Psychopharmacology 25 (11):1434–52. doi:10.1177/0269881110382466.
   PubMed Web of Science ®Google Scholar
• Tornay, L., P. A. Michaud, G. Gmel, M. L. Wilson, A. Berchtold, and J. C. Suris. 2013. Parental monitoring: A way to decrease substance use among Swiss adolescents? European Journal of Pediatrics 172 (9):1229–34. doi:10.1007/s00431-013-2029-0.
   PubMed Web of Science ®Google Scholar
• Van Ryzin, M. J., G. M. Fosco, and T. J. Dishion. 2012. Family and peer predictors of substance use from early adolescence to early adulthood: An 11-year prospective analysis. Addictive Behaviors 37 (12):1314–24. doi:10.1016/j.addbeh.2012.06.020.
   PubMed Web of Science ®Google Scholar
• Wardle, M. C., and H. de Wit. 2014. MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231 (21):4219–29. doi:10.1007/s00213-014-3570-x.
   PubMed Web of Science ®Google Scholar
• Ware, J., Jr., M. Kosinski, and S. D. Keller. 1996. A 12-Item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 34 (3):220–33.
   PubMed Web of Science ®Google Scholar